Academic–Industrial Collaboration: Toward the Consilience of Two Solitudes

Abstract

Current major advances in drug discovery can be traced back to pioneering contributions originating from academics over a century ago. Living in a symbiotic yet noninvasive coexistence, the academic community and the pharmaceutical industry have strived, each in their own way, to develop the modern medicines that benefit humankind today. The subject is presented from a historical and personal perspective.

Integrating molecular nuclear imaging in clinical research to improve anticancer therapy

“…Ultimately, radiopharmaceutical manufacturing services and academiapharma hubs, or other centres with relevant expertise, are necessary for large-scale production of PET tracers 39,[54][55][56] . When drugs themselves are radiolabelled for use in phase I/II trials to enhance pharmacological knowledge, the tracer is often produced in only a limited number of batches for use at a single centre or a few centres.…”